Jane Street’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
Other funds holding FDMT
Jane Street's FDMT Position: Q3 2026 in Review
Jane Street opened a new position in 4D Molecular Therapeutics (FDMT) in Q3 2026: 171,009 shares worth $2.45M. The stake represents ﹤0.01% of the portfolio and ranks #4807 among its holdings. This is a return to the name: Jane Street previously reported a position in FDMT as recently as Q1 2026.
Jane Street first reported a position in FDMT in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.8M in Q2 2024. 167 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.
- Jane Street held 171,009 shares of 4D Molecular Therapeutics worth $2.45M as of Q3 2026.
- 4D Molecular Therapeutics was a new Jane Street position in Q3 2026.
- 4D Molecular Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #4807 holding.
- Jane Street first reported a position in 4D Molecular Therapeutics in Q4 2022 and has held it in 14 quarters since.
- Jane Street's 4D Molecular Therapeutics position peaked at $2.8M in Q2 2024.
- 167 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.